Please login to the form below

Not currently logged in
Email:
Password:

FDA

This page shows the latest FDA news and features for those working in and with pharma, biotech and healthcare.

Pfizer to buy 8.1% stake in Valneva in support of joint Lyme disease programme

Pfizer to buy 8.1% stake in Valneva in support of joint Lyme disease programme

The programme was granted Fast Track designation by the US Food and Drug Administration (FDA) in July 2017, with Pfizer and Valneva expecting to initiate their phase 3 trial this year,

Latest news

More from news
Approximately 858 fully matching, plus 3,035 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 172 partially matching documents found.

Latest appointments

More from appointments
Approximately 6 fully matching, plus 43 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 77 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
SEVEN STONES COLLECTIVE

Hello. We are the Total Health creative agency. It’s our collective mix of talent that gets us to truly different...

Latest intelligence

Learning and development: the secret weapon for a successful life science launch
Dave Stuteville, Executive Vice President, Learning & Development, reveals the principles behind successfully training Sales Representatives and Medical Science Liaisons for a rapid biopharmaceutical product launch....
Creative awakening2
A creative awakening – how pharma is bringing innovation to the patient journey
By Danny Buckland...
MEDSCAPE EDUCATION: The Human Story in Virtual Patient Simulation
...